In this activity, there are standards of care and government mandates documentation of prognostic indicators and staging which are constantly evolving new therapeutic approaches introduced or investigated through clinical trials for cancer.
LINK:
OBJECTIVES: Upon completion of this activity, the participant should be able to:
1.Decide when surgery, chemo, immune, and/or radiation should be used for treatment for specific patients
2.Introduce new pathological tests that can provide prognostic indications for treatment decisions.
3. Identify new drug and/or treatment modalities and formulate the best treatment plan for patient cases discussed.
4. Review of the latest NCCN Guidelines and ASCO Guidelines.
ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For assistance please contact: Kimberlee Martin at [email protected].

Facebook
X
LinkedIn
Forward